Cargando…

Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies

BACKGROUND: Exploratory research showed that female oncologists are frequently under-represented in leadership roles. European Society for Medical Oncology (ESMO) Women for Oncology (W4O) therefore implemented gender equality programs in career development and established international studies on fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghoff, A.S., Sessa, C., Yang, J.C.-H., Tsourti, Z., Tsang, J., Tabernero, J., Peters, S., Linardou, H., Letsch, A., Haanen, J., Garralda, E., Garassino, M.C., Furness, A.J.S., Felip, E., Dimopoulou, G., Dafni, U., Choo, S.P., Banerjee, S., Bajpai, J., Adjei, A.A., Garrido, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710465/
https://www.ncbi.nlm.nih.gov/pubmed/34924143
http://dx.doi.org/10.1016/j.esmoop.2021.100281
_version_ 1784623159569285120
author Berghoff, A.S.
Sessa, C.
Yang, J.C.-H.
Tsourti, Z.
Tsang, J.
Tabernero, J.
Peters, S.
Linardou, H.
Letsch, A.
Haanen, J.
Garralda, E.
Garassino, M.C.
Furness, A.J.S.
Felip, E.
Dimopoulou, G.
Dafni, U.
Choo, S.P.
Banerjee, S.
Bajpai, J.
Adjei, A.A.
Garrido, P.
author_facet Berghoff, A.S.
Sessa, C.
Yang, J.C.-H.
Tsourti, Z.
Tsang, J.
Tabernero, J.
Peters, S.
Linardou, H.
Letsch, A.
Haanen, J.
Garralda, E.
Garassino, M.C.
Furness, A.J.S.
Felip, E.
Dimopoulou, G.
Dafni, U.
Choo, S.P.
Banerjee, S.
Bajpai, J.
Adjei, A.A.
Garrido, P.
author_sort Berghoff, A.S.
collection PubMed
description BACKGROUND: Exploratory research showed that female oncologists are frequently under-represented in leadership roles. European Society for Medical Oncology (ESMO) Women for Oncology (W4O) therefore implemented gender equality programs in career development and established international studies on female representation at all stages of the oncology career pathway. METHODS: For 2017-2019, data were collected on (i) first and last authorship of publications in five major oncology journals and (ii) representation of women in leadership positions in oncology—as invited speakers at National/International congresses, board members or presidents of National/International societies and ESMO members. The 2015/2016 data from the first published W4O Study were incorporated for comparisons. RESULTS: Across 2017-2019, female oncologists were significantly more likely to be first than last authors (P < 0.001). The proportion of female first authors was similar across years: 38.0% in 2017, 37.1% in 2018, 41.0% in 2019 (P = 0.063). The proportion of female last authors decreased from 30.4% in 2017 to 24.2% in 2018 (P = 0.0018) and increased to 28.5% in 2019 (P = 0.018). Across 2015-2019, invited speakers at International/National oncology congresses were significantly less likely to be female than male (P < 0.001; 29.7% in 2015 to 36.8% in 2019). Across 2016-2019, board members of International/National oncology societies were significantly less likely to be female than male (P < 0.001; 26.8% in 2016 to 35.8% in 2019). There were statistically significant increasing trends in female speakers and board members across the study periods (P < 0.001 for both). Societies with a female president had a higher proportion of female board members across these periods (P = 0.026). CONCLUSIONS: Reported progress towards gender equality in career development in oncology is real but slow. Women in leadership positions are essential for encouraging young women to aspire to and work towards similar or greater success. Therefore, continued monitoring is needed to inform ESMO W4O initiatives to promote gender balance at all stages of the career pathway.
format Online
Article
Text
id pubmed-8710465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87104652022-01-04 Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies Berghoff, A.S. Sessa, C. Yang, J.C.-H. Tsourti, Z. Tsang, J. Tabernero, J. Peters, S. Linardou, H. Letsch, A. Haanen, J. Garralda, E. Garassino, M.C. Furness, A.J.S. Felip, E. Dimopoulou, G. Dafni, U. Choo, S.P. Banerjee, S. Bajpai, J. Adjei, A.A. Garrido, P. ESMO Open Original Research BACKGROUND: Exploratory research showed that female oncologists are frequently under-represented in leadership roles. European Society for Medical Oncology (ESMO) Women for Oncology (W4O) therefore implemented gender equality programs in career development and established international studies on female representation at all stages of the oncology career pathway. METHODS: For 2017-2019, data were collected on (i) first and last authorship of publications in five major oncology journals and (ii) representation of women in leadership positions in oncology—as invited speakers at National/International congresses, board members or presidents of National/International societies and ESMO members. The 2015/2016 data from the first published W4O Study were incorporated for comparisons. RESULTS: Across 2017-2019, female oncologists were significantly more likely to be first than last authors (P < 0.001). The proportion of female first authors was similar across years: 38.0% in 2017, 37.1% in 2018, 41.0% in 2019 (P = 0.063). The proportion of female last authors decreased from 30.4% in 2017 to 24.2% in 2018 (P = 0.0018) and increased to 28.5% in 2019 (P = 0.018). Across 2015-2019, invited speakers at International/National oncology congresses were significantly less likely to be female than male (P < 0.001; 29.7% in 2015 to 36.8% in 2019). Across 2016-2019, board members of International/National oncology societies were significantly less likely to be female than male (P < 0.001; 26.8% in 2016 to 35.8% in 2019). There were statistically significant increasing trends in female speakers and board members across the study periods (P < 0.001 for both). Societies with a female president had a higher proportion of female board members across these periods (P = 0.026). CONCLUSIONS: Reported progress towards gender equality in career development in oncology is real but slow. Women in leadership positions are essential for encouraging young women to aspire to and work towards similar or greater success. Therefore, continued monitoring is needed to inform ESMO W4O initiatives to promote gender balance at all stages of the career pathway. Elsevier 2021-10-19 /pmc/articles/PMC8710465/ /pubmed/34924143 http://dx.doi.org/10.1016/j.esmoop.2021.100281 Text en © 2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Berghoff, A.S.
Sessa, C.
Yang, J.C.-H.
Tsourti, Z.
Tsang, J.
Tabernero, J.
Peters, S.
Linardou, H.
Letsch, A.
Haanen, J.
Garralda, E.
Garassino, M.C.
Furness, A.J.S.
Felip, E.
Dimopoulou, G.
Dafni, U.
Choo, S.P.
Banerjee, S.
Bajpai, J.
Adjei, A.A.
Garrido, P.
Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
title Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
title_full Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
title_fullStr Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
title_full_unstemmed Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
title_short Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
title_sort female leadership in oncology—has progress stalled? data from the esmo w4o authorship and monitoring studies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710465/
https://www.ncbi.nlm.nih.gov/pubmed/34924143
http://dx.doi.org/10.1016/j.esmoop.2021.100281
work_keys_str_mv AT berghoffas femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT sessac femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT yangjch femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT tsourtiz femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT tsangj femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT taberneroj femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT peterss femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT linardouh femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT letscha femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT haanenj femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT garraldae femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT garassinomc femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT furnessajs femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT felipe femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT dimopouloug femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT dafniu femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT choosp femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT banerjees femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT bajpaij femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT adjeiaa femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies
AT garridop femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies